Nonarteritik Anterior İskemik Optik Nöropati

Nonarteritik anterior iskemik optik nöropati (NAİON) en sık görülen iskemik optik nöropati ve glokomdan sonra en sık görülen optik nöropati çeşididir. İnflmasyon, demyelinizasyon ve kompresyonla ilgisi olmayan vasküler bir optik nöropati olup optik sinire bağlı en sık görme kaybı sebeplerindendir. 55-65 yaşları arası görülme sıklığı artan, nonarteritik anterior iskemik optik nöropati etiyopatogenez ve tedavisinde henüz birçok şey netleşmemiştir. Bu makale NAION’un patogenez, klinik bulgular, tanı ve tedavisine yönelik literatürü özetlemektedir

Nonarteritic Anterior Ischemic Optic Neuropathy

Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common ischemic optic neuropathy and the most common type of optic neuropathy aftr glaucoma. It is a vascular optic neuropathy which is not related to inflmmation, demyelinization and compression and it is the most common visual loss due to optic nerve involvement. While increased incidence between the ages of 55-65; factors affcting the etiopathogenesis and development of NAION and its treatment have not been clarified yet. Ths article summarizes the literature on the pathogenesis, clinical findings, diagnosis and treatment of NAION.

Kaynakça

1. Hayreh SS. Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis. Br J Ophthalmol. 1974;58(12):955-963.

2. Hayreh SS. Posterior ischemic optic neuropathy. Ophthalmologica 1981;182(1):29-41.

3. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123(1):103-107.

4. Levin LA, Danesh-Meyer HV. Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008;126(11):1582-1585.

5. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999;213(2):76-96.

6. Lam BL, Jabaly-Habib H, Al-Sheikh N, Pezda M, Guirgis MF, Feuer WJ. et al. Risk of non-arteritic anterior ischaemic optic neuropathy (NAION) aftr cataract extraction in the fellow eye of patients with prior unilateral NAION. Br J Ophthalmol. 2007;91(5):585-587.

7. Moradi A, Kanagalingam S, Diener-West M, Miller NR. Post-Cataract Surgery Optic Neuropathy: Prevalence, Incidence, Temporal Relationship, and Fellow Eye Involvement. Am J Ophthalmol 2017;175(3):183-193.

8. Gedik S, Yilmaz G, Akova YA. Sildenafil-associated consecutive nonarteritic anterior ischaemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in a heamodialysis patient. Eye (Lond). 2007;21(1):129-130.

9. Roth S, Moss HE. Update on Perioperative Ischemic Optic Neuropathy Associated With Non-ophthalmic Surgery. Front Neurol. 2018;9(7):557(1- 8).

10. Tesser RA, Niendorf ER, Levin LA. Th morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2003;110(10):2031-2035.

11. Schuster AK, Steinmetz P, Forster TM, Schlichtenbrede FC, Harder BC, Jonas JB. Choroidal thickness in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2014;158(6):1342-1347.e1.

12. Dias-Santos A, Ferreira J, Abegao Pinto L, Vicente A, Anjos R, Cabugueira A, et al. Choroidal Thckness in Nonarteritic Anterior Ischaemic Optic Neuropathy: A Study with Optical Coherence Tomography. Neuroophthalmology. 2014;38(4):173-179.

13. Gonul S, Gedik S, Koktekir BE, Yavuzer K, Okudan S. Evaluation of Choroidal Thckness in Non-arteritic Anterior Ischaemic Optic Neuropathy at the Acute and Chronic Stages. Neuroophthalmology. 2016;40(4):181-187.

14. Archer EL, Pepin S. Obstructive sleep apnea and nonarteritic anterior ischemic optic neuropathy: evidence for an association. J Clin Sleep Med. 2013;9(6):613-618.

15. Xin X, Huber A, Meyer P, Flammer J, Neutzner A, Miller NR et al. L-PGDS (betatrace protein) inhibits astrocyte proliferation and mitochondrial ATP production in vitro. J Mol Neurosci. 2009;39(3):366-371.

16. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114(11):1366-1374.

17. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology. 2008;115(2):298- 305.e2.

18. Hedges TR, 3rd, Vuong LN, Gonzalez-Garcia AO, Mendoza-Santiesteban CE, Amaro-Quierza ML. Subretinal flid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography. Arch Ophthalmol. 2008;126(6):812-815.

19. Serin S, Gedik S, Turgut Ozturk B, Bakbak B, Gonul S. NAİON olgularında makula değişikliklerinin spektral-domain OKT ile değerlendirilmesi. TOD 51. Ulusal Kongresi; 2017 24-29 Ekim; Antalya.

20. Atkins EJ, Bruce BB, Newman NJ, Biousse V. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2010;55(1):47-63.

21. Higashiyama T, Ichiyama Y, Muraki S, Nishida Y, Ohji M. Optical Coherence Tomography Angiography in a Patient with Optic Atrophy Aftr Non-arteritic Anterior Ischaemic Optic Neuropathy. Neuroophthalmology. 2016;40(3):146-149.

22. Chuman H, Maekubo T, Osako T, Kodama Y, Ishiai M, Nao IN. Rodent model of nonarteritic ischemic optic neuropathy and its electrophysiological evaluation. Jpn J Ophthalmol. 2012;56(5):518-27.

23. Dickersin K, Li T. Surgery for nonarteritic anterior ischemic optic neuropathy. Cochrane Database Syst Rev. 2015:12(3):Cd001538.

24. Miller GR, Smith JL. Ischemic optic neuropathy. Am J Ophthalmol 1966;62(1):103-115.

25. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246(7):1029-1046.

26. Foulds WS. Visual disturbances in systemic disorders. Optic neuropathy and systemic disease. Trans Ophthalmol Soc U K. 1970;89:125-146.

27. Chuman H, Kawano N, Kozawa M, Nao IN. Vasodilatory effcts of antivascular endothelium growth factor (VEGF) antibody, corticosteroid, and nitric oxide on the posterior ciliary arteries. Jpn J Ophthalmol 2013;57(3):320-326.

28. Bennett JL, Thmas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol. 2007;27(3):238-240.

29. Johnson LN, Guy ME, Krohel GB, Madsen RW. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107(3):521-526.

30. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123(2):212-217.

31. Kupersmith MJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol. 1997;17(4):250-253.

32. Jonas JB, Spandau UH, Harder B, Sauder G. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):749-750.

33. Kaderli B, Avci R, Yucel A, Guler K, Gelisken O. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2007;27(3):164-168.

34. Huang TL, Wen YT, Chang CH, Chang SW, Lin KH, Tsai RK. Effcacy of Intravitreal Injections of Triamcinolone Acetonide in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci. 2016;57(4):1878-1884.

35. Rootman DB, Gill HS, Margolin EA. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial. Eye (Lond). 2013;27(4):538-544.

36. Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG. Insight into 144 patients with ocular vascular events during VEGF antagonist injections. Clin Ophthalmol. 2012;6:343-363.

37. Wilhelm B, Ludtke H, Wilhelm H. Effcacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol. 2006;244(5):551-558.

38. Touitou V, Johnson MA, Guo Y, Miller NR, Bernstein SL. Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2013;54(12):7402-7409.

Kaynak Göster